This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Find out more here.

eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
New eMC coming June 2013...

BPL (Bio Products Laboratory)

Dagger Lane, Elstree, Hertfordshire, WD6 3BX
Telephone: +44 (0)20 8957 2200
Fax: +44 (0)20 8957 2601
WWW: http://www.bpl.co.uk
Medical Information Direct Line: +44 (0)20 8957 2622
Medical Information e-mail: medinfo@bpl.co.uk
Customer Care direct line: +44 (0)20 8957 2342
Medical Information Fax: +44 (0)20 8957 2611

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 31/10/2013
PIL Gammaplex, a sterile liquid of 5% w/v normal immunoglobulin

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 31/10/2013 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - use in children/adolescents
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 2 - excipient warnings
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 4 - how to report a side effect
  • Change to section 5 - how to store
  • Change to section 6 - what the product contains
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision
  • Change to other sources of information section
  • Change to section 1 - what the product is
  • Change to section 1 - what the product is used for
Updated on 19/02/2013 and displayed until 31/10/2013
Reasons for adding or updating:
  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - manufacturer
  • Change to section 6 - date of revision
  • Company name change or merger
Updated on 07/11/2012 and displayed until 19/02/2013
Reasons for adding or updating:
  • Introduction of new pack/pack size
Updated on 08/05/2012 and displayed until 07/11/2012
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 16/03/2012 and displayed until 08/05/2012
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 27/10/2009 and displayed until 16/03/2012
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 26/10/2009 and displayed until 27/10/2009
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics